GMP-certified Liraglutide API — the original GLP-1 receptor agonist behind Victoza® and Saxenda®. CEP and USDMF both on file. Complete regulatory dossier in 24 hours.
| INN / Generic Name | Liraglutide |
| CAS Number | 204656-20-2 |
| Molecular Formula | C₁₇₂H₂₆₅N₄₃O₅₁ |
| Molecular Weight | 3,751.2 g/mol |
| Mechanism / Class | GLP-1 Receptor Agonist (once-daily) |
| Therapeutic Use | Type 2 Diabetes, Chronic Weight Management (Victoza® / Saxenda® reference) |
| Purity (HPLC) | ≥98.0% |
| Appearance | White to off-white lyophilised powder |
| Storage | 2–8°C (short-term); −20°C (long-term) |
| MOQ (commercial) | 2 kg |
| MOQ (R&D) | 200 mg – 1 g |
| Lead Time | 4–8 weeks |
| Regulatory Filings | CEP + USDMF |
| Country of Origin | India / China |
Every Liraglutide API inquiry returns a complete regulatory package in 24 hours.
Submit your requirements. We'll respond with a complete package within 24 business hours.